Our study provides a comprehensive analysis into how APOE genotype influences the trajectory of AD-tau and AGD-tau pathologies by incorporating biochemical measures, thus supplementing, and enriching our understanding of the neuropathological studies previously published. The gene discussed is MAPT; the disease is Alzheimer disease.